In the BioHarmony Drug Report Database

"Preview" Icon

Anisindione

Miradon (anisindione) is a small molecule pharmaceutical. Anisindione was first approved as Miradon on 1982-01-01. It is used to treat atrial fibrillation, coronary occlusion, embolism, myocardial infarction, and pulmonary embolism amongst others in the USA. The pharmaceutical is active against vitamin K-dependent gamma-carboxylase.

 

Trade Name

 

Miradon
 

Common Name

 

anisindione
 

ChEMBL ID

 

CHEMBL712
 

Indication

 

atrial fibrillation, coronary occlusion, embolism, myocardial infarction, pulmonary embolism, thromboembolism, venous thrombosis
 

Drug Class

 

Image (chem structure or protein)

Anisindione structure rendering